We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a cost benefit analysis to evaluate your digital health product.
How to use an ethnographic study to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
How to use an interrupted time series to evaluate your digital health product.
Helping public health practitioners conducting evaluations – choosing evaluation methods.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Helping public health practitioners conducting evaluations – using economic evaluation to identify the value gained from an intervention.
What we do and how we approach regulating landlords.
Using an ecological momentary assessment to evaluate your digital health product.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Use the contents table below to jump to your specific section of interest.
How we carry out inspections of landlords
What is involved in regulatory judgements and gradings
Guidance to help organisations choose a monitoring approach for stack emissions to air that meets Environment Agency and MCERTS requirements (formerly part of M2).
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
How to use a before-and-after study to evaluate your digital health product.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.